The cost of influenza in Thailand

Vaccine
James M SimmermanViroj Tangcharoensathien

Abstract

The cost of influenza in less wealthy tropical countries is needed to inform national vaccine policy decisions. Between September 2003 and August 2004, we prospectively identified hospitalized pneumonia cases and outpatients with laboratory confirmed influenza in a Thai province. Disease incidence, patient interviews, medical record reviews, and data from a national health survey were used to calculate direct and indirect costs which were extrapolated to the Thai population. Influenza was identified in 80 (11%) of 761 hospitalized pneumonia inpatients with projected annual incidence of 18-111/100,000 population. Influenza was confirmed in 23% of 1092 outpatients with an estimated annual incidence of 1420/100,000 population. Influenza was estimated to cause between US dollar 23.4 and US dollar 62.9 million in economic losses with lost productivity accounting for 56% of all costs. The burden of influenza in Thailand is greater than previously appreciated, particularly in young children and the elderly. The impact and cost-effectiveness of influenza vaccination for high-risk groups merits further investigation.

References

Oct 1, 1992·The Journal of Infectious Diseases·H ScheiblauerR Rott
Jan 1, 1989·The Journal of the Society of Occupational Medicine·A Smith
Mar 1, 1986·The Journal of Infectious Diseases·R B CouchW A Keitel
May 1, 1997·Journal of Occupational and Environmental Medicine·D S Campbell, M H Rumley
Feb 7, 1998·American Journal of Public Health·L SimonsenL B Schonberger
May 8, 1995·Journal of Health Economics·M A KoopmanschapL van Roijen
Oct 16, 1999·Lancet·N J Cox, K Subbarao
Jul 6, 2000·The Journal of Antimicrobial Chemotherapy·T Szucs
Sep 6, 2000·Social Science & Medicine·V TangcharoensathienV Kasemsup
Oct 4, 2000·JAMA : the Journal of the American Medical Association·C B BridgesK Fukuda
Nov 4, 2000·Pediatrics·G M Cohen, M D Nettleman
Jun 12, 2001·Health Policy·K A FitznerA J Hedley
Jan 25, 2002·The Journal of Infectious Diseases·Kathleen M NeuzilPeter F Wright
Jun 25, 2002·Journal of Epidemiology and Community Health·M SegallD L Huong
Aug 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tsuneo MorishimaUNKNOWN Collaborative Study Group on Influenza-Associated Encephalopathy in Japan
Aug 16, 2002·Occupational Medicine·F W O'Reilly, A B Stevens
Dec 27, 2002·The New England Journal of Medicine·Susan S ChiuJ S Malik Peiris
Jan 9, 2003·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Jan 23, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ville PeltolaOlli Ruuskanen
Oct 11, 2003·The Pediatric Infectious Disease Journal·Nicola PrincipiPiero Crovari
Jan 20, 2004·The Pediatric Infectious Disease Journal·David S Fedson
Feb 12, 2004·JAMA : the Journal of the American Medical Association·Terho Heikkinen, Olli Ruuskanen
Feb 12, 2004·JAMA : the Journal of the American Medical Association·Tasnee Chonmaitree, James Grady
Sep 21, 2004·The Journal of Infectious Diseases·Terho HeikkinenTaina Juven
Nov 9, 2004·Vaccine·James Mark SimmermanScott F Dowell
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chong-Shan WangPesus Chou
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chit-Ming WongJ S Malik Peiris
Dec 17, 2004·The Pediatric Infectious Disease Journal·Shadi ChamanyRana A Hajjeh

❮ Previous
Next ❯

Citations

Jan 25, 2012·Bulletin of the World Health Organization·Eduardo Azziz-BaumgartnerStephen P Luby
Nov 26, 2009·PloS One·James Mark SimmermanSupamit Chunsuttiwat
Dec 25, 2009·Emerging Infectious Diseases·Yee Sin LeoAngela Chow
Oct 31, 2012·Bulletin of the World Health Organization·Wilfrido ClaraNivaldo Linares-Perez
May 1, 2007·The Pediatric Infectious Disease Journal·Scott F Dowell
Aug 17, 2010·The Journal of Infection·Mei Poh OngSamsinah Haji Hussain
Jul 25, 2009·The Lancet Infectious Diseases·Yee-Sin LeoAngela Chow
Nov 26, 2015·Vaccine·Natasha de Francisco ShapovalovaRaymond Hutubessy
Oct 23, 2008·Vaccine·Anthony T Newall, Paul A Scuffham
Jan 16, 2007·The Journal of Infection·Hang L K NguyenHiroshi Suzuki
Sep 1, 2007·Influenza and Other Respiratory Viruses·Piyarat SuntarattiwongTawee Chotpitayasunondh
May 21, 2009·Influenza and Other Respiratory Viruses·James M Simmerman, Timothy M Uyeki
Jul 19, 2012·Influenza and Other Respiratory Viruses·Herman KosasihEndang R Sedyaningsih
Jun 22, 2012·Influenza and Other Respiratory Viruses·Oliver W MorganAlicia M Fry
Feb 20, 2010·Influenza and Other Respiratory Viruses·Phengta VongphrachanhJuliet E Bryant
Apr 23, 2014·Influenza and Other Respiratory Viruses·Mejbah U BhuiyanEduardo Azziz-Baumgartner
Oct 27, 2009·Vaccine·Hien T NguyenUNKNOWN Vietnam National Influenza Surveillance and Evaluation Team
Apr 29, 2015·Influenza and Other Respiratory Viruses·Qiu Sue HuangMarc-Alain Widdowson
Apr 28, 2012·Vaccine·Tina-Marie AssiBruce Y Lee
Feb 28, 2007·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Darlene BhavnaniJames M Simmerman
Sep 23, 2006·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Sonja J OlsenScott F Dowell
Apr 17, 2015·BMC Public Health·Samuel K PeasahAnand Krishnan
Sep 24, 2013·Vaccine·Samuel K PeasahMarc-Alain Widdowson
Aug 9, 2011·Vaccine·Geraldine Blanchard-Rohner, Claire-Anne Siegrist
Jul 21, 2011·Asian Pacific Journal of Tropical Medicine·C H RasulR U Zaman
Sep 24, 2015·PloS One·Gideon O EmukuleJoshua A Mott
May 27, 2015·PLoS Medicine·Aronrag MeeyaiYot Teerawattananon
Feb 16, 2011·Scandinavian Journal of Public Health· Pengqian Fang Hongjie Yu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.